Long-term effect of the eradication of Helicobacter pylori on the hemoglobin A1c in type 2 diabetes or prediabetes patients
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: The long-term effect of Helicobacter pylori eradication on the metabolic syndrome or diabetes are unclear. The aim of this study was to evaluate the effect of H. pylori eradication on glycemic control in type 2 diabetes mellitus (T2DM) or prediabetes mellitus (preDM). Methods: A total of 124 asymptomatic subjects with T2DM or preDM were divided into H. pylori-negative (n = 40), H. pylori- positive with non-eradicated (n = 34), and eradicated (n = 50) groups. We measured H. pylori status (culture, histology, and rapid urease test) and glycated hemoglobin A1c (A1C) levels and followed-up at the 1st year and the 5th year of follow-up. Results: The A1C levels significantly decreased in the eradicated group compared to the negative group and the non-eradicated groups (at the 1st year, p = 0.024; at the 5th year, p = 0.009). The A1C levels decreased in male, and/or subjects < 65 years of age in subgroup analyses (in male subjects, p = 0.047 and p = 0.020 at the 1st and the 5th year; in subjects < 65 years of age, p = 0.028 and p = 0.006 at the 1st and the 5th year; in male subjects < 65 years of age, p = 0.039 and p = 0.032 at the 1st and the 5th year). The eradication of H. pylori was related to the decrease in A1C values throughout the follow-up period, compared to the non-eradicated group (p = 0.017). Conclusions: H. pylori eradication was related to the decreasing of A1C levels in patients with T2DM or preDM over a longterm follow-up period, especially in male and subjects < 65 years of age.
Abstract
Background/Aims: The long-term effect of Helicobacter pylori eradication on the metabolic syndrome or diabetes are unclear. The aim of this study was to evaluate the effect of H. pylori eradication on glycemic control in type 2 diabetes mellitus (T2DM) or prediabetes mellitus (preDM). Methods: A total of 124 asymptomatic subjects with T2DM or preDM were divided into H. pylori-negative (n = 40), H. pylori- positive with non-eradicated (n = 34), and eradicated (n = 50) groups. We measured H. pylori status (culture, histology, and rapid urease test) and glycated hemoglobin A1c (A1C) levels and followed-up at the 1st year and the 5th year of follow-up. Results: The A1C levels significantly decreased in the eradicated group compared to the negative group and the non-eradicated groups (at the 1st year, p = 0.024; at the 5th year, p = 0.009). The A1C levels decreased in male, and/or subjects < 65 years of age in subgroup analyses (in male subjects, p = 0.047 and p = 0.020 at the 1st and the 5th year; in subjects < 65 years of age, p = 0.028 and p = 0.006 at the 1st and the 5th year; in male subjects < 65 years of age, p = 0.039 and p = 0.032 at the 1st and the 5th year). The eradication of H. pylori was related to the decrease in A1C values throughout the follow-up period, compared to the non-eradicated group (p = 0.017). Conclusions: H. pylori eradication was related to the decreasing of A1C levels in patients with T2DM or preDM over a longterm follow-up period, especially in male and subjects < 65 years of age.
참고문헌 (46)
- Lim JH, "Inverse relationship between Helicobacter pylori infection and asthma among adults younger than 40 years: a cross-sectional study", Medicine (Baltimore), 95, pp.e2609~ (2016)
- Gunji T, "Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population", Am J Gastroenterol, 103, pp.3005~3010 (2008)
- Polyzos SA, "The association between Helicobacter pylori infection and insulin resistance : a systematic review", Helicobacter, 16, pp.79~88 (2011)
- Simon L, "The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice", Orv Hetil, 130, pp.1325~1329 (1989)
- Kayar Y, "Relationship between Helicobacter pylori infections in diabetic patients and inflammations, metabolic syndrome, and complications", Int J Chronic Dis, 2015, pp.290128~ (2015)
- Chen YY, "Helicobacter pylori infection increases risk of incident metabolic syndrome and diabetes : a cohort study", PLoS One, 14, pp.e0208913~ (2019)
- Bajaj S, "Association of helicobacter pylori infection with type 2 diabetes", Indian J Endocrinol Metab, 18, pp.694~699 (2014)
- Cornejo-Pareja I, "H. pylori eradication treatment alters gut microbiota and GLP-1 secretion in humans", J Clin Med, 8, pp.451~ (2019)
- Martin-Nunez GM, "H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota", PLoS One, 14, pp.e0213548~ (2019)
- Dogan Z, "The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels : a prospective study", Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 159, pp.242~245 (2015)
- Cheng KP, "Helicobacter pylori eradication improves glycemic control in type 2 diabetes patients with asymptomatic active Helicobacter pylori infection", J Diabetes Investig, 10, pp.1092~1101 (2019)
- Lim SH, "Positive association between Helicobacter pylori infection and metabolic syndrome in a Korean population : a multicenter nationwide study", Dig Dis Sci, 64, pp.2219~2230 (2019)
- 유수영, "Seoul National University Bundang Hospital’s Electronic System for Total Care", Healthcare Informatics Research, 18(2), pp.145~152 (2012), 대한의료정보학회[DOI]
- 김미경, "2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea", Diabetes and Metabolism Journal, 43(4), pp.398~406 (2019), 대한당뇨병학회[DOI]
- Kwang-Il Kim, "2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations", Clinical Hypertension, 25(4), pp.75~88 (2019), 대한고혈압학회[DOI]
- 이은정, "2018 Guidelines for the management of dyslipidemia", The Korean Journal of Internal Medicine, 34(4), pp.723~771 (2019), 대한내과학회[DOI]
- 서미혜, "2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea", Journal of Obesity & Metabolic Syndrome, 28(1), pp.40~45 (2019), 대한비만학회[DOI]
- 김성은, "Effect of Helicobacter pylori Eradication on Functional Dyspepsia", Journal of Neurogastroenterology and Motility (JNM), 19(2), pp.233~243 (2013), 대한소화기 기능성질환∙운동학회
- Lee JY, "Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance", Dig Dis Sci, 59, pp.1235~1243 (2014)
- Huang J, "Randomised controlled trial : sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children : a multicentre, open-labelled study", Aliment Pharmacol Ther, 38, pp.1230~1235 (2013)
- Mokhtare M, "The effects of helicobacter pylori eradication on modification of metabolic syndrome parameters in patients with functional dyspepsia", Diabetes Metab Syndr, 11(Suppl 2), pp.S1031~S1035 (2017)
- Feingold KR, "Role of cytokines in inducing hyperlipidemia", Diabetes, 41(Suppl 2), pp.97~101 (1992)
- Zhou X, "Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun", miR-203, J Gastroenterol, pp.2015, 50[DOI]
- Wellen KE, "Inflammation, stress, and diabetes", J Clin Invest, 115, pp.1111~1119 (2005)
- Chabot F, "Interrelationships between ghrelin, insulin and glucose homeostasis : physiological relevance", World J Diabetes, 5, pp.328~341 (2014)
- Patel AD, "Ghrelin stimulates insulin-induced glucose uptake in adipocytes", Regul Pept, 134, pp.17~22 (2006)
- Paoluzi OA, "Impairment of ghrelin synthesis in Helicobacter pylori-colonized stomach : new clues for the pathogenesis of H. pylori-related gastric inflammation", World J Gastroenterol, 20, pp.639~646 (2014)
- Gao XY, "Circulating ghrelin", obestatin ratio in subjects with Helicobacter pylori infection, 2009, pp.25, 506~511
- Poykko SM, "Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes", Diabetes, 52, pp.2546~2553 (2003)
- Choi YJ, "Increase in plasma acyl ghrelin levels is associated with abatement of dyspepsia following Helicobacter pylori eradication", J Gastroenterol, 51, pp.548~559 (2016)
- Rask E, "Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men", Diabetes Care, 24, pp.1640~1645 (2001)
- Holst JJ, "The physiology of glucagon-like peptide 1", Physiol Rev, 87, pp.1409~1439 (2007)
- Zietek T, "Inflammation meets metabolic disease : gut feeling mediated by GLP-1", Front Immunol, 7, pp.154~ (2016)
- Ianiro G, "Antibiotics as deep modulators of gut microbiota : between good and evil", Gut, 65, pp.1906~1915 (2016)
- Liou JM, "Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication : a multicentre, open-label, randomised trial", Lancet Infect Dis, 19, pp.1109~1120 (2019)
- Chen LW, "Helicobacter pylori infection increases insulin resistance and metabolic syndrome in residents younger than 50 years old : a community-based study", PLoS One, 10, pp.e0128671~ (2015)
- Park Y, "Eradication of Helicobacter pylori infection decreases risk for dyslipidemia : a cohort study", Helicobacter, 26, pp.e12783~ (2021)
- Buzas GM, "Metabolic consequences of Helicobacter pylori infection and eradication", World J Gastroenterol, 20, pp.5226~5234 (2014)
- Pai JK, "Inflammatory markers and the risk of coronary heart disease in men and women", N Engl J Med, 351, pp.2599~2610 (2004)
- el-Omar EM, "Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease", Gastroenterology, 109, pp.681~691 (1995)
- Jemal A, "Global cancer statistics", CA Cancer J Clin, 61, pp.69~90 (2011)
- Ohtani M, "17β-Estradiol suppresses Helicobacter pylori-induced gastric pathology in male hypergastrinemic INS-GAS mice", Carcinogenesis, 32, pp.1244~1250 (2011)
- Yu Y, "Association of Helicobacter pylori infection with metabolic syndrome in aged Chinese females", Exp Ther Med, 17, pp.4403~4408 (2019)
- Ohtani M, "Protective role of 17beta-estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice", Carcinogenesis, 28, pp.2597~2604 (2007)
- Ambikairajah A, "Lipid profile differences during menopause : a review with meta-analysis", Menopause, 26, pp.1327~1333 (2019)
- Godsland IF, "Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein(a)concentrations : analysis of studies published from 1974-2000", Fertil Steril, 75, pp.898~915 (2001)